The FDA has endorsed CaaMTech's approach to handling "functional unblinding" in its CT-4201 psilocin prodrug trials. This approval paves the way for CT-4201’s development and progress in ...
News-Medical.Net on MSN
New insights into MDMA therapy for PTSD and beyond
A comprehensive peer-reviewed invited review published today in Psychedelics by Dr. Kenji Hashimoto and colleagues (Dr.
The co, majority owned subsidiary, Biovest International (BVTI.OB), announced its regulatory strategy for its Fast Tracked Phase 3 clinical trial of its anti-cancer vaccine for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback